Speaker illustration

Miss Elsa Silva

I3s (Institute for Research and Innovation in Health), Porto (Portugal)

Member of:

Heart Failure Association

Pharmacological Targeting of Senescence with ABT-263 in Experimental Heart Failure with Preserved Ejection Fraction

Event: Frontiers in CardioVascular Biomedicine 2022

Topic: Heart Failure

Session: Moderated poster 10 - Heart Failure


The senolyitc drug ABT-263 reverses HFpEF-associated inflammation, endothelial inflammation and fibrosis

Event: Heart Failure 2021 Online Congress

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Session: Chronic Heart Failure - Pathophysiology and Mechanisms 2


This platform is supported by

logo Novo Nordisk